NCT01635751View on ClinicalTrials.gov

A Clinical Trial to Compare The Pharmacokinetics of A Pregabalin GLARS Tablet 150mg With Immediate Release Formulation and to Assess The Effect of High Fat Diet in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Healthy
Interventions
DRUG

Pregabalin

GLA5PR GLARS tablet 150mg/day(Pregabalin 150mg once a day, fasted)

DRUG

Pregabalin

GLA5PR GLARS tablet 150mg/day(Pregabalin 150mg once a day, after high fat meal)

DRUG

Pregabalin

Lyrica Capsule 150mg/day(Pregabalin 75mg twice a day, fasted)

Trial Locations (1)

137-701

The Catholic University of Korea, Seoul St.Mary's Hospital, Seochogu

Sponsors
All Listed Sponsors
lead

GL Pharm Tech Corporation

INDUSTRY

NCT01635751 - A Clinical Trial to Compare The Pharmacokinetics of A Pregabalin GLARS Tablet 150mg With Immediate Release Formulation and to Assess The Effect of High Fat Diet in Healthy Male Subjects | Biotech Hunter | Biotech Hunter